Ignite Creation Date:
2025-12-24 @ 7:14 PM
Ignite Modification Date:
2026-05-21 @ 7:26 PM
Study NCT ID:
NCT00929903
Status:
COMPLETED
Last Update Posted:
2013-09-30
First Post:
2009-06-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Childhood Central Nervous System Choriocarcinoma | View |
| None | Childhood Central Nervous System Embryonal Tumor | View |
| None | Childhood Central Nervous System Germ Cell Tumor | View |
| None | Childhood Central Nervous System Germinoma | View |
| None | Childhood Central Nervous System Mixed Germ Cell Tumor | View |
| None | Childhood Central Nervous System Teratoma | View |
| None | Childhood Central Nervous System Yolk Sac Tumor | View |
| None | Metastatic Childhood Soft Tissue Sarcoma | View |
| None | Recurrent Childhood Brain Stem Glioma | View |
| None | Recurrent Childhood Central Nervous System Embryonal Tumor | View |
| None | Recurrent Childhood Soft Tissue Sarcoma | View |
| None | Recurrent Childhood Visual Pathway Glioma | View |
| None | Unspecified Childhood Solid Tumor, Protocol Specific | View |
Keywords: